Nextech Invest, Ltd. Context Therapeutics Inc. Transaction History
Nextech Invest, Ltd.
- $528 Billion
- Q2 2025
A detailed history of Nextech Invest, Ltd. transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Nextech Invest, Ltd. holds 7,419,355 shares of CNTX stock, worth $10.4 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
7,419,355
Previous 7,419,355
-0.0%
Holding current value
$10.4 Million
Previous $4.54 Billion
7.06%
% of portfolio
0.92%
Previous 1.06%
Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
43Shares Held
75.9MCall Options Held
0Put Options Held
0-
Bio Impact Capital LLC Cambridge, MA14.7MShares$20.6 Million1.9% of portfolio
-
Avidity Partners Management LP Dallas, TX7.48MShares$10.5 Million1.33% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$10.4 Million0.17% of portfolio
-
Nextech Invest Ag7.42MShares$10.4 Million1.37% of portfolio
-
Blue Owl Capital Holdings LP New York, NY7.41MShares$10.4 Million2.65% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $22.4M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...